These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 7581970)

  • 21. Cholinergic modulation of growth hormone, prolactin and thyroid stimulating hormone responses to thyrotropin-releasing hormone in normal aging.
    Giusti M; Giovale M; Sessarego P; Carraro A; Pompei A; Giordano G
    Recenti Prog Med; 1995 Sep; 86(9):341-4. PubMed ID: 7569294
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Corticotropin-releasing hormone inhibition of paradoxical growth hormone response to thyrotropin-releasing hormone in insulin-dependent diabetics.
    Barbarino A; Corsello SM; Tofani A; Sciuto R; Della Casa S; Rota CA; Colasanti S; Barini A
    Metabolism; 1992 Sep; 41(9):949-53. PubMed ID: 1355581
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Arginine stimulates growth hormone secretion by suppressing endogenous somatostatin secretion.
    Alba-Roth J; Müller OA; Schopohl J; von Werder K
    J Clin Endocrinol Metab; 1988 Dec; 67(6):1186-9. PubMed ID: 2903866
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Growth hormone response to the hypothalamic somatostatinergic activity in acromegalic patients.
    Yang I; Park S; Woo J; Kim S; Kim J; Kim Y; Choi Y
    J Clin Endocrinol Metab; 1997 Aug; 82(8):2492-6. PubMed ID: 9253323
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impaired inhibitory effects of somatostatin on growth hormone (GH)-releasing hormone stimulation of GH secretion after short term infusion.
    Kelijman M; Frohman LA
    J Clin Endocrinol Metab; 1990 Jul; 71(1):157-63. PubMed ID: 1973420
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human prolactin and thyrotropin concentrations in the serums of normal and hypopituitary children before and after the administration of synthetic thyrotropin-releasing hormone.
    Foley TP; Jacobs LS; Hoffman W; Daughaday WH; Blizzard RM
    J Clin Invest; 1972 Aug; 51(8):2143-50. PubMed ID: 4626583
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Studies on the mechanism of growth hormone and thyrotropin responses to somatostatin antiserum in anesthetized rats.
    Chihara K; Arimura A; Chihara M; Schally AV
    Endocrinology; 1978 Nov; 103(5):1916-23. PubMed ID: 107024
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pituitary hormone responses to hypothalamic releasing hormones in acromegaly.
    Cantalamessa L; Reschini E; Catania A; Giustina G
    Acta Endocrinol (Copenh); 1976 Dec; 83(4):673-83. PubMed ID: 826061
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pyridostigmine effects on TSH response to TRH in adult and children obese subjects.
    Mancini A; Fiumara C; Conte G; Sammartano L; Fabrizi ML; Iacona T; Valle D; De Marinis L
    Horm Metab Res; 1993 Jun; 25(6):309-11. PubMed ID: 8344646
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Discordant effects of insulin-hypoglycemia on growth hormone (GH)-releasing hormone-stimulated GH and thyrotropin (TSH)-releasing hormone-stimulated TSH secretion.
    Kelijman M; Frohman LA
    J Clin Endocrinol Metab; 1988 Apr; 66(4):872-5. PubMed ID: 3126217
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term treatment of acromegaly with Sandostatin (SMS 201-995). Normalization of most anomalous growth hormone responses.
    Pieters GF; van Liessum PA; Smals AG; van Gennep JA; Benraad TJ; Kloppenborg PW
    Acta Endocrinol Suppl (Copenh); 1987; 286():9-18. PubMed ID: 2892339
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Growth hormone release inhibiting hormone: actions on thyrotrophin and prolactin secretion after thyrotrophinreleasing hormone.
    Carr D; Gomez-Pan A; Weightman DR; Roy VC; Hall R; Besser GM; Thorner MO; McNeilly AS; Schally AV; Kastin AJ; Coy DH
    Br Med J; 1975 Jul; 3(5975):67-9. PubMed ID: 806323
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of repetitive administration of thyrotropin-releasing hormone at short intervals in acromegaly.
    Losa M; Alba-Roth J; Sobieszczyk S; Schopohl J; Müller OA; von Werder K
    Acta Endocrinol (Copenh); 1989 Mar; 120(3):383-9. PubMed ID: 2494827
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Low hexarelin dose and pyridostigmine have additive effect and potentiate to the same extent the GHRH-induced GH response in man.
    Arvat E; Di Vito L; Ramunni J; Gianotti L; Giordano R; Deghenghi R; Camanni F; Ghigo E
    Clin Endocrinol (Oxf); 1997 Oct; 47(4):495-500. PubMed ID: 9404449
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of the cholinergic pathway in growth hormone feedback.
    Kelijman M; Frohman LA
    J Clin Endocrinol Metab; 1991 May; 72(5):1081-7. PubMed ID: 1902484
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bromocriptine suppression of TRH-stimulated prolactin and thyrotrophin release and accompanying inhibition of bromocriptine induced growth hormone release by TRH in normal man.
    Brown PM; Bacchus R; Sachs L; Sönksen PH; Wheeler M
    Clin Endocrinol (Oxf); 1979 May; 10(5):481-8. PubMed ID: 113143
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of somatostatin on thyrotropin, prolactin, growth hormone and insulin responses to thyrotropin releasing hormone and arginine in healthy, hypothyroid and acromegalic subjects.
    Faure N; Dussault JH; Nadeau A; Szots F; Guyda H; Labrie F
    Can Med Assoc J; 1977 Sep; 117(5):478-81. PubMed ID: 409475
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prolactin and thyrotrophin responses to thyroliberin (TRH) in patients with growth hormone deficiency: study in 167 patients.
    Garnier PE; Roger M; Chaussain JL; Canlorbe P; Job JC
    Acta Endocrinol (Copenh); 1983 Aug; 103(4):433-40. PubMed ID: 6412497
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cholinergic control of growth hormone (GH) responses to GH-releasing hormone in insulin dependent diabetics: evidence for attenuated hypothalamic somatostatinergic tone and decreased GH autofeedback.
    Ismail IS; Scanlon MF; Peters JR
    Clin Endocrinol (Oxf); 1993 Feb; 38(2):149-57. PubMed ID: 8094648
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hypothalamic hormone interaction in acromegaly.
    Gomez-Pan A; Tunbridge WM; Duns A; Hall R; Besser GM; Coy DH; Schally AV; Kastin AJ
    Clin Endocrinol (Oxf); 1975 Sep; 4(5):455-60. PubMed ID: 170027
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.